Published on 22 Apr 2024 on Simply Wall St. via Yahoo Finance
With 80% ownership, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) boasts of strong institutional...
Key Insights
Significantly high institutional ownership implies BioCryst Pharmaceuticals' stock price is sensitive to their trading actionsThe top 13 shareholders own 51% of the companyUsing data from analyst forecasts alongside ownership research, one can better assess the future performance of a company
Every investor in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) should be aware of the most powerful shareholder groups. With 80% stake, institutions possess the maximum shares in the company. Put another way, the group faces the maximum upside potential (or downside risk).